Cutler Group’s Foundation Medicine, Inc. FMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-5,399
Closed -$738K 5092
2018
Q2
$738K Buy
5,399
+2,453
+83% +$223K 0.06% 332
2018
Q1
$231K Sell
2,946
-254
-8% -$18.7K 0.02% 752
2017
Q4
$218K Buy
+3,200
New +$166K 0.01% 906
2017
Q3
Sell
-1,031
Closed -$39.8K 7243
2017
Q2
$40K Buy
+1,031
New +$37.8K ﹤0.01% 2735
2017
Q1
Sell
-1,100
Closed -$27.4K 7711
2016
Q4
$19K Buy
1,100
+300
+38% +$6.46K ﹤0.01% 3539
2016
Q3
$18K Sell
800
-1,600
-67% -$36.3K ﹤0.01% 3565
2016
Q2
$44K Sell
2,400
-4,692
-66% -$84.8K ﹤0.01% 2494
2016
Q1
$128K Buy
7,092
+900
+15% +$14.5K 0.01% 1379
2015
Q4
$130K Buy
+6,192
New +$119K 0.01% 1546

Cutler Group's FMI Position: Q3 2018 in Review

Cutler Group sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 5,399 shares — an estimated $738K sold.

Cutler Group first reported a position in FMI in Q4 2015 and held it in 9 quarters. The position peaked at $738K in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

  • Cutler Group reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
  • Cutler Group sold 5,399 Foundation Medicine, Inc. shares in Q3 2018, an estimated $738K.
  • Cutler Group first reported a position in Foundation Medicine, Inc. in Q4 2015 and held it in 9 quarters.
  • Cutler Group's Foundation Medicine, Inc. position peaked at $738K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.

Based on Cutler Group's 13F filing for Q3 2018, filed 7 Nov 2018.